As of 2024-12-11, the EV/EBITDA ratio of Biodesix, Inc. (BDSX) is -6.72. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Biodesix,'s latest enterprise value is 196.76 mil USD. Biodesix,'s TTM EBITDA according to its financial statements is -29.27 mil USD. Dividing these 2 quantities gives us the above Biodesix, EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.4x - 9.0x | 8.6x |
| Forward P/E multiples | 8.9x - 10.6x | 9.3x |
| Fair Price | (1.83) - (1.85) | (1.84) |
| Upside | -238.5% - -240.3% | -239.3% |
| Date | EV/EBITDA |
| 2024-11-29 | -7.32 |
| 2024-11-27 | -7.24 |
| 2024-11-26 | -7.29 |
| 2024-11-25 | -6.77 |
| 2024-11-22 | -6.52 |
| 2024-11-21 | -6.12 |
| 2024-11-20 | -6.07 |
| 2024-11-19 | -6.32 |
| 2024-11-18 | -6.42 |
| 2024-11-15 | -6.85 |
| 2024-11-14 | -7.12 |
| 2024-11-13 | -7.12 |
| 2024-11-12 | -7.12 |
| 2024-11-11 | -7.17 |
| 2024-11-08 | -6.97 |
| 2024-11-07 | -6.77 |
| 2024-11-06 | -6.77 |
| 2024-11-05 | -6.82 |
| 2024-11-04 | -7.07 |
| 2024-11-01 | -6.62 |
| 2024-10-31 | -8.61 |
| 2024-10-30 | -8.41 |
| 2024-10-29 | -8.36 |
| 2024-10-28 | -8.11 |
| 2024-10-25 | -8.31 |
| 2024-10-24 | -8.26 |
| 2024-10-23 | -8.01 |
| 2024-10-22 | -8.16 |
| 2024-10-21 | -8.11 |
| 2024-10-18 | -8.16 |
| 2024-10-17 | -8.26 |
| 2024-10-16 | -8.41 |
| 2024-10-15 | -8.21 |
| 2024-10-14 | -8.11 |
| 2024-10-11 | -8.56 |
| 2024-10-10 | -8.61 |
| 2024-10-09 | -8.31 |
| 2024-10-08 | -8.51 |
| 2024-10-07 | -8.56 |
| 2024-10-04 | -8.56 |
| 2024-10-03 | -8.56 |
| 2024-10-02 | -8.86 |
| 2024-10-01 | -8.96 |
| 2024-09-30 | -9.01 |
| 2024-09-27 | -8.66 |
| 2024-09-26 | -8.61 |
| 2024-09-25 | -8.61 |
| 2024-09-24 | -8.51 |
| 2024-09-23 | -8.06 |
| 2024-09-20 | -9.11 |